Literature DB >> 16339969

Efficient suppression of FGF-2-induced ERK activation by the cooperative interaction among mammalian Sprouty isoforms.

Kei-ichi Ozaki1, Satsuki Miyazaki, Susumu Tanimura, Michiaki Kohno.   

Abstract

Strict regulation of the receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase (ERK) pathway is essential for maintaining balanced growth in multi-cellular organisms. Several negative regulators of the pathway have been identified which include Sprouty proteins. Mammalian cells express four Sprouty isoforms (Sprouty1-4) in an ERK-dependent manner. In this study, we have examined the molecular mechanisms by which Sprouty proteins elicit their inhibitory effects on the RTK/ERK pathway, with special focus on the co-operation among Sprouty isoforms. The four mammalian Sprouty isoforms interact with each other, most probably to form hetero- as well as homo-oligomers through their C-terminal domains. Sprouty1 specifically interacts with Grb2, whereas Sprouty4 interacts with Sos1. Although any of the Sprouty isoforms by itself inhibits the fibroblast growth factor-2 (FGF-2)-induced activation of the ERK pathway significantly, hetero-oligomers show a more pronounced inhibitory activity. The hetero-oligomer formed between Sprouty1 and Sprouty4 exhibits the most potent inhibitory effect on ERK activation through its highly effective ability to suppress the association of Grb2-Sos1 complex with FRS2. The cooperative interactions observed among Sprouty isoforms could represent an advanced system that functions to regulate strictly the activation state of the RTK/ERK pathway in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339969     DOI: 10.1242/jcs.02711

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  25 in total

1.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

2.  Negative regulation of lens fiber cell differentiation by RTK antagonists Spry and Spred.

Authors:  Guannan Zhao; Charles G Bailey; Yue Feng; John Rasko; Frank J Lovicu
Journal:  Exp Eye Res       Date:  2018-03-01       Impact factor: 3.467

3.  Targeted Sprouty1 overexpression in cardiac myocytes does not alter myocardial remodeling or function.

Authors:  Nathan J Charles; Robert C Huebert; Sangjin Lee; Neeta Adhikari; Sean Polster; James E Rider; Elizabeth Braunlin; Ami Mariash; Maggie Robledo; David Schuweiler; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2010-05-12       Impact factor: 3.396

4.  Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.

Authors:  Sergi Aranda; Mónica Alvarez; Silvia Turró; Ariadna Laguna; Susana de la Luna
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

5.  Overexpression of Spry1 in chondrocytes causes attenuated FGFR ubiquitination and sustained ERK activation resulting in chondrodysplasia.

Authors:  Xuehui Yang; Lauren K Harkins; Olga Zubanova; Anne Harrington; Dmitry Kovalenko; Robert J Nadeau; Pei-Yu Chen; Jessica L Toher; Volkhard Lindner; Lucy Liaw; Robert Friesel
Journal:  Dev Biol       Date:  2008-06-09       Impact factor: 3.582

Review 6.  Intermolecular interactions of Sprouty proteins and their implications in development and disease.

Authors:  Francis Edwin; Kimberly Anderson; Chunyi Ying; Tarun B Patel
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

7.  Human Sprouty1 suppresses growth, migration, and invasion in human breast cancer cells.

Authors:  Ahmed H Mekkawy; Mohammad H Pourgholami; David L Morris
Journal:  Tumour Biol       Date:  2014-02-08

8.  FGF13 regulates proliferation and differentiation of skeletal muscle by down-regulating Spry1.

Authors:  Hongzhao Lu; Xine Shi; Guofang Wu; Jiayu Zhu; Chengchuang Song; Qiangling Zhang; Gongshe Yang
Journal:  Cell Prolif       Date:  2015-07-31       Impact factor: 6.831

9.  SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150.

Authors:  A Barbáchano; A Fernández-Barral; F Pereira; M F Segura; P Ordóñez-Morán; E Carrillo-de Santa Pau; J M González-Sancho; D Hanniford; N Martínez; A Costales-Carrera; F X Real; H G Pálmer; J M Rojas; E Hernando; A Muñoz
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

10.  Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.

Authors:  Kristin C Hicks; Tarun B Patel
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.